The CAR-T & Cellular Therapy Focus on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company) and Legend Biotech. These supporters have no influence over the production of the content.
Welcome to CAR-T & Cellular Therapy Focus
Explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.
CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although various questions remain open, it is essential that healthcare professionals understand these therapies, including recognizing and managing their toxicities, and when and how to use them.
Latest CAR-T and Cellular Therapy Videos
View all
View CAR-T and Cellular Therapy Videos by Disease Area
View CAR-T and Cellular Therapy Videos by Topic
View CAR-T and Cellular Therapy Videos by Therapy Type
The CAR-T & Cellular Therapy Focus on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company) and Legend Biotech.
These supporters have no influence over the production of the content.
If you are interested in becoming a supporter of The CAR-T & Cellular Therapy Focus, please contact us.
